Rutherfold, NJ - According to Emily Badger of NJBiz, "Cancer Genetics Inc., a provider of DNA-based cancer diagnostics, announced Monday that it has agreed to acquire the assets and operations of Los Angeles-based Response Genetics Inc. Rutherford-based Cancer Genetics said in a news release that as part of the transaction, Response Genetics, a solid tumor molecular diagnostics, has filed chapter 11 bankruptcy in the Delaware Bankruptcy Court."
|
New Brunswick, NJ - Rutgers University Cell and DNA Repository (RUCDR) Infinite Biologics , BioRealm, LLC, and – Affymetrix, Inc. announced a broad strategic alliance. This alliance will leverage BioRealm's SmokeScreen® platform to genotype the National Institute on Drug Abuse (NIDA) biorepository of more than 50,000 samples, collected from human subjects studied in NIDA-funded research. NIDA preserves these samples in a biorepository at RUCDR Infinite Biologics, on the campus of Rutgers University.
Trenton, NJ – Enhancing the administration's firm commitment to finding new and innovative ways to help New Jersey families impacted by autism, First Lady Mary Pat Christie and Health Commissioner Mary E. O’Dowd today announced $4.4 million in grants to establish Autism Medical Homes and the advance research in the understanding, prevention, evaluation and treatment of the biologically-based disorder. New Jersey is a national leader in early intervention and education of children with autism which affects about 1 in 45 children across the Garden State.
New Brunswick, NJ - Joachim Messing, director of Rutgers University’s Waksman Institute of Microbiology, has been selected to membership in the National Academy of Sciences, one of the highest honors an American scientist or engineer can achieve. Messing, who is considered to be among the world’s top experts in molecular genetics, was among 84 new members elected and recognized this year for their distinguished and continuing achievements in original research.
Rutherford, NJ - Cancer Genetics, Inc., a leader in DNA-based cancer diagnostics, announced the launch of Focus::Myeloid™, a next-generation sequencing (NGS) based panel for myeloid cancers including acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN). The Focus::Myeloid™ panel will be performed in CGI’s CLIA certified lab.
Eatontown, NJ - American CryoStem Corporation a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular technologies for the Regenerative and Personalized Medicine industries, today announced the acquisition of Biolife Cell Bank’s (Biolife) adipose tissue and adipose derived stem cell banking services assets.
Princeton, NJ - According to Catherine Zandonella of the Office of the Dean for Research, "A new study from Princeton University researchers sheds light on the handing over of genetic control from mother to offspring early in development. Learning how organisms manage this transition could help researchers understand larger questions about how embryos regulate cell division and differentiation into new types of cells."
New Brunswick, NJ – Rutgers, The State University of New Jersey, developed a new Business Portal, designed in consultation with industry leaders to serve New Jersey’s corporate community. The Business Portal offers users easy access to four key areas—research, technology licensing, professional development and recruiting—and provides two robust internal search functions and clear pathways to Rutgers’ Corporate Engagement Team, Office of Research Commercialization and Rutgers Translational Sciences.
Princeton, NJ - According to Catherine Zandonella, Office of the Dean for Research, "A new study has identified genes involved in long-term memory in the worm as part of research aimed at finding ways to retain cognitive abilities during aging. The study, which was published in the journal Neuron, identified more than 750 genes involved in long-term memory, including many that had not been found previously and that could serve as targets for future research, said senior author Coleen Murphy, an associate professor of molecular biology and the Lewis-Sigler Institute for Integrative Genomics at Princeton University."
|
Do not miss a single innovative moment and sign up for our newsletter!
|
